Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Net Income towards Common Stockholders (2009 - 2026)

Illumina's (ILMN) quarterly Net Income towards Common Stockholders came in at $207.0 million in Q2 2026, down 11.91% on a YoY basis from $235.0 million in Q2 2025, and up 54.48% quarter-over-quarter from $134.0 million in Q1 2026.

Analysis

Illumina (ILMN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Illumina (ILMN) has reported Net Income towards Common Stockholders for 18 consecutive years, with $207.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 11.91% year-over-year to $207.0 million; the trailing twelve-month figure through Jun 2026 stood at $825.0 million (down 34.42% YoY), and the FY2025 full-year result was $850.0 million, up 169.5% from the prior year.
  • Net Income towards Common Stockholders rose to $207.0 million in Q2 2026 per ILMN's latest filing, from $134.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $705.0 million in Q3 2024 and bottomed at -$5.1 billion in Q1 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$583.9 million across 5 years, with a median of $44.5 million in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 206.86% in 2024, down 4300.0% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at -$3.8 billion in 2022, then soared by 95.41% to -$175.0 million in 2023, then soared by 206.86% to $187.0 million in 2024, then surged by 78.61% to $334.0 million in 2025, then slumped by 38.02% to $207.0 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $207.0 million, $134.0 million, and $334.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 1.76 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 362.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 207.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 51.82 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -17.93 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -62.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 207.00 Mn
Mar 29, 2026 134.00 Mn
Dec 28, 2025 334.00 Mn
Sep 28, 2025 150.00 Mn
Jun 29, 2025 235.00 Mn
Mar 30, 2025 131.00 Mn
Dec 29, 2024 187.00 Mn
Sep 29, 2024 705.00 Mn
Jun 30, 2024 -1.99 Bn
Mar 31, 2024 -126.00 Mn
Dec 31, 2023 -175.00 Mn
Oct 1, 2023 -754.00 Mn
Jul 2, 2023 -234.00 Mn
Apr 2, 2023 3.00 Mn
Jan 1, 2023 -5.05 Bn
Oct 2, 2022 -3.82 Bn
Jul 3, 2022 -535.00 Mn
Apr 3, 2022 86.00 Mn
Oct 3, 2021 317.00 Mn
Jul 4, 2021 185.00 Mn